India Completes Clinical Trials Of World's 1st Injectable Male Contraceptive
NDTV
The findings of the phase-III clinical trial, which involved 303 candidates aged 25-40 years, were published in the international open access Andrology journal last month.
The Indian Council of Medical Research (ICMR) has completed the clinical trials of the world's first injectable male contraceptive which showed that it is safe and highly efficacious without any serious side effects.
The findings of the phase-III clinical trial, which involved 303 candidates aged 25-40 years, were published in the international open access Andrology journal last month.
The open-labelled and non-randomized, multi-centre hospital-based phase-III clinical trials were carried out at five different centres (New Delhi, Udhampur, Ludhiana, Jaipur and Kharagpur) and coordinated by the ICMR, New Delhi. Permission to conduct phase-III clinical trial was granted by the Drugs Controller General India (DCGI) and approved by the institutional ethical committees of the respective centres.
